$DNTH
Dianthus Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DNTH down today? It is at $110.77 (-1.54%), and our scanner flagged it 35 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DNTH spikes, and full due diligence on DNTH — key stats, earnings, dilution and insider activity. Free.
Get free $DNTH alerts the moment volume spikes
Our scanner flagged $DNTH 35 times in the last 30 days. Create a free account to track $DNTH, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $110.77
- Change today
- -1.54%
- Previous close
- $112.50
- 52-week range
- $18.08 – $114.55
- Market cap
- $6.15B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 9.2M ▼ -3% vs prior · as of 2026-07-15
- Days to cover
- 8.9d
- Avg daily volume
- 866K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.2x
- 15m
- 0.3x
- 1hthin
- 0.4x
- 1D
- 0.0x
Get free DNTH + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $DNTH down today?
DNTH is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on DNTH today.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Smart money in $DNTH
All smart money →- FAFisher Asset Management (Fisher) increased its positionAs of Q2 2026 holdings · filed Aug 4, 2026$2M13F-HR ↗
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
Insiders
Insiders selling0 buys, 4 sells last 3 months (0/15 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Savitz Ryan Officer | Sold (automatic/other) | -31K 0.06% of company | n/a | n/a | $3.1M at $100.22 | Jul 9, 26 |
Savitz Ryan Officer | Other | 31K 0.06% of company | n/a | 31K | $680K at $21.77 | Jul 9, 26 |
Veness Adam M Officer | Sold (automatic/other) | -30K 0.05% of company | n/a | n/a | $2.4M at $80.34 | Jun 17, 26 |
Veness Adam M Officer | Other | 30K 0.05% of company | n/a | 30K | $536K at $17.88 | Jun 17, 26 |
Randhawa Simrat Officer | Sold (automatic/other) | -27K 0.05% of company | sold 87% | 4K | $2.4M at $89.72 | Jun 1, 26 |
Randhawa Simrat Officer | Other | 27K 0.05% of company | added 100% | 31K | $224K at $8.44 | Jun 1, 26 |
Soteropoulos Paula Director | Sold (automatic/other) | -599 | n/a | n/a | $51K at $85.47 | May 8, 26 |
Soteropoulos Paula Director | Other | 599 | n/a | 599 | $5K at $8.44 | May 8, 26 |
Savitz Ryan Officer | Sold (automatic/other) | -8K 0.02% of company | n/a | n/a | $739K at $89.84 | Apr 9, 26 |
Savitz Ryan Officer | Other | 8K 0.02% of company | n/a | 8K | $147K at $17.88 | Apr 9, 26 |
Soteropoulos Paula Director | Sold (automatic/other) | -599 | n/a | n/a | $48K at $80.11 | Mar 31, 26 |
Soteropoulos Paula Director | Other | 599 | n/a | 599 | $5K at $8.44 | Mar 31, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $DNTH runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $81.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$DNTH Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$DNTH Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to DNTH
Comparable names in pharmaceutical preparations, closest in size first.
DNTH stock FAQ
Why is $DNTH down today?
DNTH is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on DNTH today.
What is the DNTH stock price today?
DNTH last traded at $110.77, down 1.54% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live DNTH alerts?
The DNTH Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DNTH 35 times in the last 30 days.
What exchange is DNTH on?
DNTH (Dianthus Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $6.15B in the PHARMACEUTICAL PREPARATIONS sector.
Is DNTH good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DNTH for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.